TD Cowen Rates Stevanato Group S.p.A. (STVN) buy

TD Cowen reaffirms its buy rating for Stevanato Group with a $25 price target, a 47.58% upside from the current price.

By EarningsIQ Research Desk · Published Jun 16, 2026, 2:01 PM EDT · Updated Jun 23, 2026, 10:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

TD Cowen rated Stevanato Group S.p.A. ($STVN) "buy" with a $25 price target on June 16, 2026.

Since the rating, $STVN is up 2.2% after 1 week, up 21.7% after 1 month and up 14.5% to date (from the $16.51 close on Jun 16, 2026).

STVN Stevanato Group S.p.A.

$18.90 -7.85% year to date

Daily close · Oct 16, 2026

Key Points

TD Cowen reiterated its buy rating for Stevanato Group S.p.A. on June 16, 2026, with a price target of $25.
TD Cowen's $25 price target implies 47.58% upside from Stevanato Group S.p.A.'s ($STVN) current $16.94 share price.
Stevanato Group's stock is trading around $16.63 with a market cap of $4.54 billion and a P/E ratio of 28.19.
Recent insider selling includes Mauro Stocchi's sale of 12,888 shares on June 12, 2025, at an average price of $21.56.

Get $STVN trade alerts by text

We text you when insiders, Congress or big funds trade $STVN. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stevanato Group S.p.A. alert may contain errors. Disclosures

TD Cowen has reiterated its buy rating for Stevanato Group S.p.A. (NYSE: STVN) on June 16, 2026, maintaining a price target of $25. This move reflects the firm's confidence in the company's future performance.

Stevanato Group S.p.A. Stock Down 12.3%

Shares of NYSE:STVN are currently trading near $16.63. Stevanato Group boasts a market capitalization of approximately $4.54 billion and has a P/E ratio of 28.19. The company's stock has a 52-week low of $12.89 and a high of $28.00, with a 50-day moving average of $16.92 and a 200-day moving average of $19.80. The firm maintains a current ratio of 1.63 and a quick ratio of 1.11, alongside a debt-to-equity ratio of 29.43.

12-month forecast

$STVN price target

Stevanato Group S.p.A. daily closes and this analyst's $25 target. Not advice.

Recent Earnings

Stevanato Group reported revenues of $1.20 billion, reflecting a growth rate of 6.6%. The company's earnings per share (EPS) stand at $0.59, with a net margin of 11.75% and a return on equity (ROE) of 9.59%. The next earnings date is anticipated on August 4, 2026.

Dividend

The company pays an annual dividend rate of $0.06 per share, yielding 0.37% with a dividend payout ratio of 10.59%.

Insider Buying and Selling at Stevanato Group S.p.A.

Recent insider activity includes sales by Mauro Stocchi, who sold 12,888 shares on June 12, 2025, at an average price of $21.56, and Franco Moro, who sold 13,500 shares on June 14, 2023, at a price of $30.85.

Analysts Set New Price Targets

On June 16, 2026, TD Cowen reiterated its buy rating for Stevanato Group with a price target of $25. Earlier, on June 2, 2026, Wolfe Research assumed coverage with a buy rating and a $21 target. Morgan Stanley maintained a hold rating with a $19 target on March 6, 2026, while Citigroup and Keybanc both maintained buy ratings with targets of $26 and $32, respectively, on March 5, 2026. The consensus recommendation is a buy, with an average target price of $24.39 based on nine analyst opinions.

About Stevanato Group S.p.A.

Stevanato Group S.p.A. is a healthcare company based in Piombino Dese, Italy. It designs and produces products for the biopharma and healthcare industries, operating in sectors like medical instruments and supplies. The company offers a range of solutions including drug containment and delivery systems, diagnostic solutions, and engineering services. Founded in 1949, it employs over 6,000 people and serves a global market.

Bottom Line

TD Cowen's reiterated buy rating for Stevanato Group suggests continued optimism about the company's prospects. With a strong market position and recent earnings growth, Stevanato remains a company to watch in the healthcare sector. As always, investors should remember that analyst ratings are based on past data and projections, which may not reflect future performance.